Tobii Dynavox AB (publ)

PINK:TDVXF USA Medical Instruments & Supplies
Market Cap
$671.31 Million
Market Cap Rank
#9094 Global
#4440 in USA
Share Price
$6.36
Change (1 day)
+0.00%
52-Week Range
$5.93 - $6.36
All Time High
$6.36
About

Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with impaired communication skills. The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own. Its com… Read more

Tobii Dynavox AB (publ) (TDVXF) - Net Assets

Latest net assets as of December 2025: $603.00 Million USD

Based on the latest financial reports, Tobii Dynavox AB (publ) (TDVXF) has net assets worth $603.00 Million USD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.47 Billion) and total liabilities ($1.87 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $603.00 Million
% of Total Assets 24.37%
Annual Growth Rate 65.43%
5-Year Change 332.26%
10-Year Change N/A
Growth Volatility 70.9

Tobii Dynavox AB (publ) - Net Assets Trend (2019–2025)

This chart illustrates how Tobii Dynavox AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Tobii Dynavox AB (publ) (2019–2025)

The table below shows the annual net assets of Tobii Dynavox AB (publ) from 2019 to 2025.

Year Net Assets Change
2025-12-31 $603.00 Million +32.91%
2024-12-31 $453.70 Million +52.35%
2023-12-31 $297.80 Million +41.41%
2022-12-31 $210.60 Million +50.97%
2021-12-31 $139.50 Million +1584.04%
2020-12-31 $-9.40 Million -131.97%
2019-12-31 $29.40 Million --

Equity Component Analysis

This analysis shows how different components contribute to Tobii Dynavox AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1744.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings $640.00 Million 106.14%
Common Stock $1.00 Million 0.17%
Total Equity $603.00 Million 100.00%

Tobii Dynavox AB (publ) Competitors by Market Cap

The table below lists competitors of Tobii Dynavox AB (publ) ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Tobii Dynavox AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 454,000,000 to 603,000,000, a change of 149,000,000 (32.8%).
  • Net income of 166,000,000 contributed positively to equity growth.
  • Other factors decreased equity by 17,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $166.00 Million +27.53%
Other Changes $-17.00 Million -2.82%
Total Change $- 32.82%

Book Value vs Market Value Analysis

This analysis compares Tobii Dynavox AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.12x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 21.59x to 1.12x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 $0.29 $6.36 x
2020-12-31 $-0.09 $6.36 x
2021-12-31 $1.39 $6.36 x
2022-12-31 $2.00 $6.36 x
2023-12-31 $2.79 $6.36 x
2024-12-31 $4.31 $6.36 x
2025-12-31 $5.66 $6.36 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Tobii Dynavox AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 27.53%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.73%
  • • Asset Turnover: 1.00x
  • • Equity Multiplier: 4.10x
  • Recent ROE (27.53%) is below the historical average (52.76%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 230.27% 7.45% 1.17x 26.47x $64.76 Million
2020 0.00% 14.50% 1.22x 0.00x $130.74 Million
2021 21.36% 3.42% 0.76x 8.22x $15.85 Million
2022 23.08% 4.00% 0.92x 6.28x $27.54 Million
2023 34.96% 6.45% 0.95x 5.67x $74.32 Million
2024 32.16% 7.40% 0.99x 4.40x $100.60 Million
2025 27.53% 6.73% 1.00x 4.10x $105.70 Million

Industry Comparison

This section compares Tobii Dynavox AB (publ)'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $771,083,081
  • Average return on equity (ROE) among peers: -146.50%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Tobii Dynavox AB (publ) (TDVXF) $603.00 Million 230.27% 3.10x $644.46 Million
ANGELALIGN TECHNOLOGY INC (AGLFF) $520.03 Million 8.62% 0.25x $405.57 Million
Akoya Biosciences Inc (AKYA) $-30.16 Million 0.00% 0.00x $16.24 Million
Alcon AG (ALC) $2.56 Billion 36.42% 1.05x $36.83 Billion
Align Technology Inc (ALGN) $161.15 Million 22.17% 0.38x $11.50 Billion
AngioDynamics Inc (ANGO) $372.19 Million 2.67% 0.10x $344.14 Million
Ansell Limited (ANSLF) $1.56 Billion 10.20% 0.61x $2.58 Billion
AptarGroup Inc (ATR) $2.07 Billion 11.57% 1.03x $7.93 Billion
AtriCure Inc (ATRC) $483.76 Million 10.38% 0.27x $1.38 Billion
Avinger Inc (AVGR) $4.24 Million -1323.46% 11.63x $1.26 Million
Anteris Technologies Global Corp. Common Stock (AVR) $18.90 Million -243.53% 0.62x $156.14 Million